Enrofloxacin Market Size 2020 Industry Overview Growth Analysis, Regional Demand, Future Scope and Forecast To 2027

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Request Sample: https://www.coherentmarketinsights.com/insight/request-sample/2742

Market Overview

Enrofloxacin (ENR) is a fluoroquinolone antibiotic and a veterinary antibacterial agent. It is sold under the trade name Baytril by the Bayer Corporation. ENR is currently approved by the U.S. Food and Drug Administration (FDA) for treatment of individual pets and domestic animals in the U.S.  ENR is effective against a several gram-positive and gram-negative bacteria such as Pseudomonas aeruginosa, Klebsiella, and E.coli. It is used for the treatment of infections of the skin and soft tissue, urinary tract infections in dogs and cats, Chlamydophila felis infections in cats, and ulcerative colitis caused by Escherichia coli in dogs. The market is expected to gain significant growth due to growth in the poultry sector.

The global enrofloxacin market size is projected to witness potential growth in the future, and register a significant CAGR over the forecast period (2019 – 2027).

Key Players

Some of the major players operating in the global enrofloxacin market include Bayer Corporation, KRKA d.d., Novo Mesto, Pro Zoon, Chanelle Pharmaceuticals, VetMedic, and VM Pharma.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2742

Market Dynamics

The growing use of ENR in the treatment of infections caused by both gram-negative and gram-positive bacteria is expected to boost market growth. ENR is administered to cattle by subcutaneous injection and to pigs by intramuscular injection. It is administered orally to cattle, pigs, turkey, and chickens, for the treatment of infections of the respiratory and alimentary tract.

However, in rare instances, the use of ENR in cats may lead to retinal toxicity as this drug cannot be used in pets that are allergic to it. ENR is also associated with some side effects such as vomiting, diarrhea, and lack of appetite. Moreover, in September 2005, enrofloxacin was withdrawn from use in the U.S. poultry farms. These factors are projected to hinder the growth of the enrofloxacin market over the forecast period.

The rising trend of adopting pets is expected to offer lucrative opportunities for market players to enhance their market share.

Market Outlook

The Asia Pacific is projected to hold a dominant position in the enrofloxacin market over the forecast period. Factors such as growing population and high demand for poultry meat are projected to impact the market growth. Moreover, significant growth in the pet industry in China is also projected to contribute to the market growth in the Asia Pacific. Whereas, restrictions on the use of ENR in the U.S. are expected to adversely affect the growth of the market in North America.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.